RCEL vs LUNG

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

RCEL

46.1
AI Score
VS
LUNG Wins

LUNG

61.2
AI Score

Investment Advisor Scores

RCEL

46score
Recommendation
HOLD

LUNG

61score
Recommendation
BUY

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric RCEL LUNG Winner
Revenue 40.95M 43.34M LUNG
Net Income -18.27M -23.73M RCEL
Gross Margin 81.8% 78.0% RCEL
Net Margin -44.6% -54.8% RCEL
Operating Income -15.66M -22.01M RCEL
ROE 65.6% -60.6% RCEL
ROA -38.2% -20.7% LUNG
Total Assets 47.78M 114.73M LUNG
Cash 9.14M 55.84M LUNG
Current Ratio 0.41 4.32 LUNG
Free Cash Flow -13.70M -15.32M RCEL

Relative Price Performance (Last 90 Days)

RCEL 1M: +40.8% · 3M: +234.5% LUNG 1M: -6.0% · 3M: +60.7%

Current Technical Phase

RCEL

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (37.2% over 20 days), RSI 78

RSI (14): 78.4 · Price: $15.42

LUNG

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 50

RSI (14): 50.1 · Price: $1.88

Fundamentals Snapshot

Metric RCEL LUNG
Market Cap — —
Forward P/E -25.6 -2.0
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.2% 0.0%
Gross Margin 0.8% 0.8%
Operating Margin -0.3% -0.4%
EPS -1.43 -1.15
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, LUNG is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.